VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1560141
Sex: F
Age:
State: TN

Vax Date: 01/13/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Right arm was throbbing; whole right arm went numb; swollenness in her arm; tingling in her arm; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollenness in her arm), PARAESTHESIA (tingling in her arm), PAIN (Right arm was throbbing) and HYPOAESTHESIA (whole right arm went numb) in a 66-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01L20A and 01LZ0A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollenness in her arm) and PARAESTHESIA (tingling in her arm). On 21-Feb-2021, the patient experienced HYPOAESTHESIA (whole right arm went numb). On 21-Feb-2021 at 6:30 PM, the patient experienced PAIN (Right arm was throbbing). The patient was treated with GABAPENTIN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and Manual therapy (Therapeutic touch treatment) for Paraesthesia. On 28-Apr-2021, PAIN (Right arm was throbbing) and HYPOAESTHESIA (whole right arm went numb) had resolved. At the time of the report, PERIPHERAL SWELLING (swollenness in her arm) and PARAESTHESIA (tingling in her arm) outcome was unknown. Treatment included Heating Pad. No concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received on 4-May-2021, reporter details, medical history, vaccination details(anatomical location), events and treatment details were added

Other Meds:

Current Illness: Diabetes

ID: 1560142
Sex: M
Age: 81
State: FL

Vax Date: 01/01/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Feb-2021 and was forwarded to Moderna on 18-Feb-2021. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The patient's past medical history included Colonoscopy (Normal) in 2019. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 17-FEB-2021 the patient experienced Inflammatory bowel condition Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: No specific follow-up information recorded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1560143
Sex: F
Age: 54
State: SC

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: feel blah; achy; 103 F fever; injection arm pain; injection arm lymph nodes swollen like a baseball; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain) and VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache). The patient was treated with IBUPROFEN at a dose of 800,400 milligram. At the time of the report, MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitants provided.

Other Meds:

Current Illness:

ID: 1560144
Sex: F
Age: 80
State: MD

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: unable to stand; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (unable to stand) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. COMD19 and 012A21A) for COVID-19 vaccination. The patient's past medical history included Myasthenia gravis. Concurrent medical conditions included Hypertension and Food allergy (Allergic to iodine). Concomitant products included METOPROLOL and LISINOPRIL for Hypertension, PYRIDOSTIGMINE BROMIDE (MESTINON) and PREDNISONE for Myasthenia gravis, AMLODIPINE, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) and LORAZEPAM for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DYSSTASIA (unable to stand). On 12-Feb-2021, DYSSTASIA (unable to stand) had resolved. Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant follow up received 20JUL 2021and concomitant medication were updated, patient demographics and medical history updated.

Other Meds: MESTINON; METOPROLOL; LISINOPRIL; AMLODIPINE; VALACYCLOVIR HCL; LORAZEPAM; PREDNISONE

Current Illness: Food allergy (Allergic to iodine)

ID: 1560145
Sex: F
Age: 67
State: MI

Vax Date: 02/18/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: very fatigued today; mild headache that progressed to a migraine; mild headache that progressed to a migraine; fatigue, muscle aches, and vomiting.; fatigue, muscle aches, and vomiting.; fatigue, muscle aches, and vomiting.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.), VOMITING (fatigue, muscle aches, and vomiting.) and FATIGUE (very fatigued today) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.), VOMITING (fatigue, muscle aches, and vomiting.) and MIGRAINE (mild headache that progressed to a migraine). On 02-Mar-2021, the patient experienced FATIGUE (very fatigued today). At the time of the report, HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.) and VOMITING (fatigue, muscle aches, and vomiting.) was resolving, FATIGUE (very fatigued today) outcome was unknown and MIGRAINE (mild headache that progressed to a migraine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1560146
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: sore arm; arm hard to hold up; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, arm hard to hold up. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) sore arm, arm hard to hold up. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), sore arm, arm hard to hold up was unknown.

Other Meds:

Current Illness:

ID: 1560147
Sex: F
Age: 61
State: NY

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Elevated heart bit 137bpm; oxygen level went down (90%); Typical pain arm (L injection); Body ache; Extreme fatigue; Joint pain; Fever (101?F is significant for her, because she typically has 96-97?F); Chills; Headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included MONTELUKAST SODIUM (SINGULAIR), THIAMPHENICOL (IGRALIN) and ETHAMBUTOL DIHYDROCHLORIDE (ATB) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101?F is significant for her, because she typically has 96-97?F)), CHILLS (Chills) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced TACHYCARDIA (Elevated heart bit 137bpm) and OXYGEN SATURATION DECREASED (oxygen level went down (90%)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101?F is significant for her, because she typically has 96-97?F)), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 101 f (High) High. On 28-Feb-2021, Heart rate: 137 bpm (High) High. On 28-Feb-2021, Oxygen saturation: 90 % (Low) Low. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other concomitant medications included admix, sibotal 40 mg, immune deficiency medications (H2 and H2 peptide).

Other Meds: SINGULAIR; IGRALIN; ATB

Current Illness:

ID: 1560148
Sex: F
Age: 73
State: NC

Vax Date: 01/21/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: rash on her back; rash on lesft side of injection arm; rash on her breast; shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm), RASH (rash on her breast) and HERPES ZOSTER (shingles) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension (Controlled high blood pressure). Concomitant products included TAMOXIFEN for Breast cancer, LOSARTAN POTASSIUM (COZAAR) for Hypertension. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm), RASH (rash on her breast) and HERPES ZOSTER (shingles). On 10-Mar-2021, HERPES ZOSTER (shingles) had resolved. At the time of the report, RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm) and RASH (rash on her breast) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Date of Birth of patient, first and second dose details, events after second dose were added On 29-Apr-2021: Patient's details such as height, weight, race and ethnicity, medical history, concomitant medications, outcome of event (shingles) changed

Other Meds: COZAAR; TAMOXIFEN

Current Illness: Hypertension (Controlled high blood pressure)

ID: 1560149
Sex: F
Age: 71
State: IL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Arm warm; Arm swollen; Could not sleep on arm; arm really tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm really tender) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination. The patient's past medical history included COVID-19. Concurrent medical conditions included Cholesterol. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm really tender). At the time of the report, VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm really tender) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Other concomitant medications included beta blockers and cholesterol medications. Treatment information was not reported.

Other Meds: WELLBUTRIN

Current Illness: Cholesterol

ID: 1560150
Sex: F
Age:
State: CA

Vax Date: 02/04/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: diarrhea; Lost of appetite; extreme tired; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (Lost of appetite), FATIGUE (extreme tired) and MYALGIA (muscle aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced FATIGUE (extreme tired) and MYALGIA (muscle aches). On 09-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and DECREASED APPETITE (Lost of appetite). On 09-Feb-2021, FATIGUE (extreme tired) and MYALGIA (muscle aches) had resolved. On 10-Feb-2021, DIARRHOEA (diarrhea) and DECREASED APPETITE (Lost of appetite) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1560151
Sex: F
Age: 73
State:

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Brain Fog; Arm very sore; Chills at night time; Fatigue; nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time) and FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Arthritis. Concomitant products included FISH OIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Body Aches), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea). On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Brain Fog). At the time of the report, PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment provided.

Other Meds: FISH OIL; VITAMINS A & D

Current Illness:

ID: 1560152
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: sore in arm; sore in thigh; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore in arm) and MYALGIA (sore in thigh) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore in arm) and MYALGIA (sore in thigh). At the time of the report, MYALGIA (sore in arm) and MYALGIA (sore in thigh) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Unable to capture reporter's contact details for further followup. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1560153
Sex: F
Age: 58
State: NY

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: chills; fatigue; headache; diarrhea; couldn't get out of bed for two days; lots of sweating; knot at injection site; body aching; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating) and INJECTION SITE NODULE (knot at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (body aching), INJECTION SITE NODULE (knot at injection site) and INJECTION SITE PAIN (pain at injection site). On an unknown date, the patient experienced DIARRHOEA (diarrhea), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), INJECTION SITE NODULE (knot at injection site), HEADACHE (headache), INJECTION SITE PAIN (pain at injection site), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no relevant concomitant medications was reported. No treatment information was provided Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1560154
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Having aches; Slight diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Having aches) and DIARRHOEA (Slight diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) UNK dosage form. On an unknown date, the patient experienced PAIN (Having aches) and DIARRHOEA (Slight diarrhea). At the time of the report, PAIN (Having aches) and DIARRHOEA (Slight diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no relevant concomitant medications was reported. No treatment information was provided

Other Meds:

Current Illness:

ID: 1560155
Sex: M
Age: 63
State: MT

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: muscle pain, burning sensation and falling off, terrible pain in his muscles; joint pain; soreness in his mouth, burning inside his mouth; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (soreness in his mouth, burning inside his mouth), RASH (Rash), ARTHRALGIA (joint pain) and MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced RASH (Rash). On 13-Feb-2021, the patient experienced ORAL PAIN (soreness in his mouth, burning inside his mouth). On 22-Feb-2021, the patient experienced ARTHRALGIA (joint pain). On 26-Feb-2021, the patient experienced MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles). On 11-Feb-2021, RASH (Rash) had resolved. At the time of the report, ORAL PAIN (soreness in his mouth, burning inside his mouth), ARTHRALGIA (joint pain) and MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment and concomitant medicines were not included Action taken with mRNA-1273 in response to the event was unknown

Other Meds:

Current Illness:

ID: 1560156
Sex: F
Age: 76
State: WA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: injection arm extremely sore; Body Aches; chills; Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing), VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing). On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills). On 09-Feb-2021, DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing) had resolved. At the time of the report, VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported. No treatment of these events were reported. This case was linked to MOD-2021-239296 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Update new dose-1 event and dose-2 information. On 02-Aug-2021: Non-Significant Follow-up, Reporter's contact details updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1560157
Sex: F
Age:
State: OK

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Thinks the site of injection was too low; Injection also hurt; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no relevant concomitant medications was reported. No treatment information was provided Med Info Agent: Maximiliano Cengarle Crosslink with Case MOD21-042058 Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non-Significant Follow up: AE contact information updated.

Other Meds:

Current Illness:

ID: 1560158
Sex: M
Age: 53
State: TX

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: had 140/87 mmhg of blood pressure; chills; nausea; headache; sore right arm; A spontaneous report was received from a consumer who is 53 year male who experienced a headache, chills, nausea, vaccination site pain, and increased blood pressure. The patient's medical history was not provided. Concomitant product included losartan 100 mg daily, atorvastatin 40 mg daily, and baby aspirin. On 25-FEB-2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Batch number: 024M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 25-FEB-2021 the patient reports experiencing soreness in the his right arm until 27-FEB-2021. On 28-FEB-2021 he developed a headache, then on 01-MAR-2021 he began having chills and nausea, and also mentioned having a blood pressure of140/87 mmhg (reports his normal levels are around 126-129/79 mmhg) Action taken with mRNA-1273 in response to the event(s) was not provided/unknown. The outcome of the events, headache, chills, nausea, pain in right arm, and increased blood pressure, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: ATORVASTATIN; LOSARTAN; ASPIRIN 81

Current Illness:

ID: 1560159
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: vaccination site sore; Minor rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash). At the time of the report, VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash) outcome was unknown. Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560160
Sex: F
Age: 73
State: OH

Vax Date: 02/20/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: itching at the injection site; Redness at the injection site; looks like a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment a beta blocker, a blood thinner and thyroid medicine.

Other Meds:

Current Illness:

ID: 1560161
Sex: M
Age: 49
State: TX

Vax Date: 02/21/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: experiencing bad ringing in both ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (experiencing bad ringing in both ears) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030m20a and 042l20a) for COVID-19 vaccination. Concomitant products included LOSARTAN and METOPROLOL for an unknown indication. On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced TINNITUS (experiencing bad ringing in both ears). At the time of the report, TINNITUS (experiencing bad ringing in both ears) had not resolved. Treatment medication included lipo flavonoid Action taken with mRNA-1273 in response to the event was not applicable

Other Meds: LOSARTAN; METOPROLOL

Current Illness:

ID: 1560162
Sex: F
Age: 62
State: FL

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: 3" red hot circle at the injection site; left elbow started bothering her; left arm started itching/more left arm itching; hard lump at the injection site; warm left arm; tender left arm; mild soreness in her left arm; little fogginess; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess), INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Drug allergy (Levaquin and cipro.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches). On 26-Feb-2021, the patient experienced INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm). On 28-Feb-2021, the patient experienced VACCINATION SITE REACTION (left elbow started bothering her) and VACCINATION SITE PRURITUS (left arm started itching/more left arm itching). On 01-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site). On 21-Feb-2021, PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches) had resolved. At the time of the report, INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm), TENDERNESS (tender left arm), VACCINATION SITE REACTION (left elbow started bothering her), VACCINATION SITE PRURITUS (left arm started itching/more left arm itching) and VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment provided

Other Meds: SYNTHROID; LIOTHYRONINE

Current Illness:

ID: 1560163
Sex: U
Age:
State: NJ

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: fatigue; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81) and ATORVASTATIN for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown. Action taken with mRNA-1273 in response to the events was not Applicable. No treatment medications provided by the reporter.

Other Meds: LEVOTHYROXINE; ASPIRIN 81; ATORVASTATIN

Current Illness:

ID: 1560164
Sex: F
Age: 70
State: CA

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Traumatic experience; Lethargic/Not motivated; got very sick; Fever 100.5F; Chills; Pounding headache; swelling in the arm (Injection Site); Sweating; Trembling; This spontaneous case was reported by a health care professional and describes the occurrence of HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated) and ILLNESS (got very sick) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 15-Jan-2021. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), TREMOR (Trembling), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)). On an unknown date, the patient experienced INJURY (Traumatic experience). At the time of the report, HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 100.5f (High) 100.5F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560165
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: loss of appetite; achy; lower back pain; cold sweats; Chills; tired; fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Arthritis and Hip replacement (two hip replacement.). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102). On 01-Mar-2021, DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. No concomitant information was provided.

Other Meds:

Current Illness:

ID: 1560166
Sex: M
Age:
State: TX

Vax Date: 02/09/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness around the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In February 2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medication details were not reported by the reporter. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1560167
Sex: F
Age: 56
State: TX

Vax Date: 02/01/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Developed a little knot on the eye; This spontaneous case was reported by an other health care professional and describes the occurrence of EYELID THICKENING (Developed a little knot on the eye) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 011M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included GLIMEPIRIDE (AMARYL), PROGESTERONE, SPIRONOLACTONE, HYDROXYCHLOROQUINE, CEVIMELINE and THYROID (ARMOUR THYROID) for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced EYELID THICKENING (Developed a little knot on the eye). At the time of the report, EYELID THICKENING (Developed a little knot on the eye) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in responsible to the events were not applicable No treatment information was provided

Other Meds: AMARYL; PROGESTERONE; SPIRONOLACTONE; HYDROXYCHLOROQUINE; CEVIMELINE; ARMOUR THYROID

Current Illness:

ID: 1560168
Sex: F
Age: 69
State: FL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe red streaks; Red blotches on palms of hand; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand). On 10-Feb-2021, RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560169
Sex: F
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: swollen; red circle; Tiny little bumps; warm to the touch; Chills; Horrific migraine; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle) and MASS (Tiny little bumps) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension, Atrial fibrillation and Arthritis. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch). On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch) outcome was unknown. Treatment included none concomitants -high blood pressure medicine, blood thinner This case was linked to MOD-2021-030483 (Patient Link).

Other Meds:

Current Illness: Arthritis; Atrial fibrillation; Hypertension

ID: 1560170
Sex: F
Age: 78
State: MN

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Rash above the right ankle up to six inches that is tender and hot to touch; Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch; Diarrhea; Muscle pain; Rash above the right ankle up to six inches that is tender and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch). At the time of the report, FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication were not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1560171
Sex: F
Age: 76
State: IN

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Actinic keratosis; Getting very depressed; A lichenoid drug eruption; Hypersensitivity reaction; Lichenoid photodermatitis; Strange looking rash on the rest of my arm; Rash from the injection site; A bright red itchy rash from the injection site, down the arm, she also spots down towards the elbow area; Arm pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACTINIC KERATOSIS (Actinic keratosis), DRUG ERUPTION (A lichenoid drug eruption), HYPERSENSITIVITY (Hypersensitivity reaction), LICHENOID KERATOSIS (Lichenoid photodermatitis) and PAIN IN EXTREMITY (Arm pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy and Nickel sensitivity. Concomitant products included VITAMINS NOS and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 23-Feb-2021, the patient experienced RASH PRURITIC (A bright red itchy rash from the injection site, down the arm, she also spots down towards the elbow area), RASH (Strange looking rash on the rest of my arm) and VACCINATION SITE RASH (Rash from the injection site). On 01-Jun-2021, the patient experienced DRUG ERUPTION (A lichenoid drug eruption), HYPERSENSITIVITY (Hypersensitivity reaction) and LICHENOID KERATOSIS (Lichenoid photodermatitis). On an unknown date, the patient experienced ACTINIC KERATOSIS (Actinic keratosis) and DEPRESSION (Getting very depressed). The patient was treated with FLUOROURACIL (topical) for Rash, at a dose of 5%, 1 dosage form; TRIAMCINOLONE ACETONIDE (topical) for Itching, at a dose of 1 dosage form and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) (topical) for Itching, at a dose of 1 dosage form. At the time of the report, ACTINIC KERATOSIS (Actinic keratosis), DRUG ERUPTION (A lichenoid drug eruption), HYPERSENSITIVITY (Hypersensitivity reaction), LICHENOID KERATOSIS (Lichenoid photodermatitis), PAIN IN EXTREMITY (Arm pain) and DEPRESSION (Getting very depressed) outcome was unknown and RASH PRURITIC (A bright red itchy rash from the injection site, down the arm, she also spots down towards the elbow area), RASH (Strange looking rash on the rest of my arm) and VACCINATION SITE RASH (Rash from the injection site) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jun-2021, Biopsy: abnormal (abnormal) Biopsy by Punch Method- Sections shows a band-like infiltrate of lymphocytes and eosinophils which focally obscures the dermal-epidermal junction with vacuolar change. On 01-Jun-2021, Periodic acid Schiff stain: negative (Negative) PAS stain does not highlight fungal organisms or spores. Control stains appropriately. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment was provided. Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Added patient demographics, medical history (allergy), laboratory tests, 2nd dose of vaccine information, concomitant medications, treatment medications and new events (Actinic keratosis, A lichenoid drug eruption, Hypersensitivity reaction, Lichenoid photodermatitis, Strange looking rash on the rest of my arm, Getting very depressed). The outcome of the events changed (from resolving to not resolved).

Other Meds: VITAMINS NOS; ASPIRIN 81

Current Illness: Drug allergy; Nickel sensitivity

ID: 1560172
Sex: F
Age: 80
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Itchy Sensation - Near Injection Site; Redness - Near Injection Site; Rash - Near Injection Site; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history was reported). On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 01-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site). On 21-Feb-2021, PAIN IN EXTREMITY (Arm pain) had resolved. At the time of the report, INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment "Ointment" - Self medicating to try to alleviate the symptoms. No concomitants provided

Other Meds:

Current Illness:

ID: 1560173
Sex: F
Age:
State: FL

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Warmth; Pain at injection site; Itchy; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was reported Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1560174
Sex: F
Age: 67
State: MS

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Tired or heavy feeling 5 days after 1st dose; Red itchy area at vaccine site after 1st dose; Red itchy area at vaccine site after 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose), INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose) and FATIGUE (Tired or heavy feeling 5 days after 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose) and INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose). On 01-Mar-2021, the patient experienced FATIGUE (Tired or heavy feeling 5 days after 1st dose). At the time of the report, INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose) and INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose) had resolved and FATIGUE (Tired or heavy feeling 5 days after 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications or treatment details reported.

Other Meds:

Current Illness:

ID: 1560175
Sex: M
Age: 70
State: FL

Vax Date: 02/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) on 02-Mar-2021 for Headache, at an unspecified dose and frequency. On 02-Mar-2021, HEADACHE (headache) had resolved. Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events were not applicable.

Other Meds:

Current Illness:

ID: 1560176
Sex: F
Age:
State:

Vax Date: 02/23/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Light-headed; Headache; Swollen eyelids and the area below; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Swollen eyelids and the area below), HEADACHE (Headache) and DIZZINESS (Light-headed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced SWELLING OF EYELID (Swollen eyelids and the area below). On 27-Feb-2021, the patient experienced HEADACHE (Headache). On 01-Mar-2021, the patient experienced DIZZINESS (Light-headed). At the time of the report, SWELLING OF EYELID (Swollen eyelids and the area below), HEADACHE (Headache) and DIZZINESS (Light-headed) outcome was unknown. No concomitant medications or treatment details reported. Reported that all symptoms are ongoing and refused to give any other information because she was only seeking for medical advice about what to do and if she should go back to the ER.

Other Meds:

Current Illness:

ID: 1560177
Sex: U
Age:
State: OH

Vax Date: 02/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in arm) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Soreness in arm). At the time of the report, MYALGIA (Soreness in arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications or treatment details reported.

Other Meds:

Current Illness:

ID: 1560178
Sex: F
Age: 55
State: NY

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,; bruise at injection site; swollen at the injection site; headache; itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 001A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Blood disorder (Von-Willebrand.) and Drug allergy (Tylenol allergy). Concomitant products included VITAMINS NOS for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache) and INJECTION SITE PRURITUS (itchiness at the injection site). On 28-Feb-2021, the patient experienced CONTUSION (bruise at injection site). On 01-Mar-2021, the patient experienced RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Reported that patient called her doctor and sent her to an allergist. No other treatment details provided.

Other Meds: VITAMINS NOS

Current Illness: Blood disorder (Von-Willebrand.); Drug allergy (Tylenol allergy)

ID: 1560179
Sex: F
Age: 76
State: NJ

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; A spontaneous report was received from a type concerning a 76-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, itching and rash on arm 2 weeks after 1st dose. The patient's medical history was not provided. Concomitant medications reported were tamoxifen, latanoprost, timolol, levothyroxine, crestor, baby aspirin, coenzyme q10, lisinopril, vitamin d, omega-3, proair for drug use for unknown indication. On 13 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011mz0a) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) redness, itching and rash on arm 2 weeks after 1st dose. Treatment details included Benadryl. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), redness, itching and rash on arm 2 weeks after 1st dose was unknown.

Other Meds: TAMOXIFEN; LATANOPROST; TIMOLOL; LEVOTHYROXINE; CRESTOR; BABY ASPIRIN; COENZYME Q-GEL; LISINOPRIL; VITAMIN D 2000; OMEGA-3 & -6 COMPLEX; PROAIR BRONQUIAL

Current Illness:

ID: 1560180
Sex: F
Age: 81
State:

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: she felt bad but not that bad; severe muscle pain; fatigue; headaches; bad nausea; severe symptoms that were worse than the flu"; A spontaneous report () was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea, she felt bad but not that bad. The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 Feb 2021, prior to the onset of the events the patient received first dose of mRNA-1273 (lot/batch: 013A21A) intramuscularly for prophylaxis of COVID-19 infection. On 27 Feb 2021, the patient experienced the event(s) severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea for several hours. On 27 Feb 2021, the patient experienced the event(s) she felt bad but not that bad. Treatment details included Tylenol and something for the nausea. Action taken with mRNA-1273 in response to the events was not reported. On28 Feb 2021 she felt good again.

Other Meds:

Current Illness:

ID: 1560181
Sex: F
Age: 71
State: OH

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Upper back muscle pains; Sore arm; A spontaneous report was received from a consumer concerning a female patient of 71-years-old,who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, upper back muscle pains. The patient's medical history was not provided. No relevant concomitant medications were reported. On 2 Mar 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On 2 Mar 2021, the patient experienced the event(s) sore arm, upper back muscle pains. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. The outcome of event(s), sore arm, upper back muscle pains was unknown.

Other Meds:

Current Illness:

ID: 1560182
Sex: F
Age: 70
State:

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: felt ill; felt achy and nauseated but had no temperature; felt achy and nauseated but had no temperature; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported by the reporter. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature). At the time of the report, MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Blood glucose increased: (Inconclusive) Increased. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications reported were chemotherapy drug. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1560183
Sex: F
Age: 53
State: TN

Vax Date: 02/02/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: headache; nausea; Fever 98.7 to 100; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea) and PYREXIA (Fever 98.7 to 100) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever 98.7 to 100). On an unknown date, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, HEADACHE (headache) and NAUSEA (nausea) had resolved and PYREXIA (Fever 98.7 to 100) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 98.7 to 100f (High) 98.7 to 100F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560184
Sex: F
Age: 58
State: TN

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Blood pressure kind of high; Severe headache; very nauseated; light headed; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), HYPERTENSION (Blood pressure kind of high), DIZZINESS (light headed), HEADACHE (Severe headache) and NAUSEA (very nauseated) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). Concomitant products included Ozempic, Lisinopril and ATORVASTATIN for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 28-Feb-2021, the patient experienced DIZZINESS (light headed) and NAUSEA (very nauseated). On 01-Mar-2021, the patient experienced HYPERTENSION (Blood pressure kind of high) and HEADACHE (Severe headache). At the time of the report, PAIN IN EXTREMITY (arm was sore), HYPERTENSION (Blood pressure kind of high), DIZZINESS (light headed), HEADACHE (Severe headache) and NAUSEA (very nauseated) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: Ozempic; LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1560185
Sex: F
Age: 71
State: CA

Vax Date: 01/22/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Herpes simplex 1; This spontaneous case was reported by a health care professional and describes the occurrence of HERPES SIMPLEX (Herpes simplex 1) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included VALSARTAN and METFORMIN for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced HERPES SIMPLEX (Herpes simplex 1). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) ongoing from 14-Feb-2021 at a dose of 1 dosage form. At the time of the report, HERPES SIMPLEX (Herpes simplex 1) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication also included Glycoside NOS. As per follow up, patient states not being diagnosed with Herpes Simplex and no more information. Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Significant information added-Event Outcome updated.

Other Meds: VALSARTAN; METFORMIN

Current Illness:

ID: 1560186
Sex: F
Age: 79
State: CT

Vax Date: 01/13/2021
Onset Date: 01/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Flu like symptoms; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included BENAZEPRIL, ATORVASTATIN, PANTOPRAZOLE, OXYBUTYNIN HYDROCHLORIDE (OXYBUTININ ACCORD), VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL), HYDROCHLOROTHIAZIDE, ALENDRONATE SODIUM (FOSAMAX), CALCIUM, MAGNESIUM and VITAMIN D3 for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications Benazepril, Atorvastatin, Pantoprazole, oxybutynin, valacyclovir hcl , hydrochlorothiazide, Fosamax, Calcium, magnesium, vitamin D3 Treatment information was not provided.

Other Meds: BENAZEPRIL; ATORVASTATIN; PANTOPRAZOLE; OXYBUTININ ACCORD; VALACYCLOVIR HCL; HYDROCHLOROTHIAZIDE; FOSAMAX; CALCIUM; MAGNESIUM; VITAMIN D3

Current Illness:

ID: 1560187
Sex: F
Age: 76
State: CA

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: extreme pain in her arm and legs/ arm hurt to touch; flue like symptoms; night sweat; extreme pain in her joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme pain in her arm and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (extreme pain in her arm and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints). At the time of the report, PAIN IN EXTREMITY (extreme pain in her arm and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints) outcome was unknown. No relevant Concomitant medications were reported. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1560188
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Immune thrombocytopenic purpura. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low). At the time of the report, BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness: Immune thrombocytopenic purpura

ID: 1560189
Sex: F
Age: 76
State: ME

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Small amount of leakage down her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Small amount of leakage down her arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE DISCHARGE (Small amount of leakage down her arm). On 27-Feb-2021, VACCINATION SITE DISCHARGE (Small amount of leakage down her arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1560190
Sex: M
Age: 68
State: FL

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Arm Pain; SPike in fever of 100.8; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8). At the time of the report, PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 100.8. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm